Publications of Xi Tan, PhD

Predicting late-stage breast cancer diagnosis and receipt of adjuvant therapy: applying current spatial access to care methods in Appalachia.
Donohoe J, Marshall V, Tan X, Camacho FT, Anderson R, Balkrishnan R.
Med Care. 2015;53(11):980-988.


Multiple chronic conditions and healthcare costs among adults.
Sambamoorthi U, Tan X, Deb A.
Expert Rev Pharmacoecon.Outcomes Res. 2015;15(5):823-832.


The impact of access to cancer care on adjuvant endocrine therapy use among breast cancer survivors in Appalachia.
Tan X, Marshall V, Camacho F, Anderson RT, Balkrishnan R.
Value in Health. 2015;18(3):A215-A215.

Adjuvant therapy use among Appalachian breast cancer survivors.
Tan X, Marshall VD, Anderson RT, Donohoe J, Camacho F, Balkrishnan R.
Medicine (Baltimore). 2015;94(26):e1071


Psychotropic medication adherence among community-based individuals with developmental disabilities and mental illness.
Tan X, Marshall VD, Balkrishnan R, Patel I, Chang J, Erickson SR.
J Ment Health Res Intellect Disabil. 2015;8(1):1-22.

Markov chain modelling analysis of HIV/AIDS progression: a race-based forecast in the United States.
Lee S, Ko J, Tan X, Patel I, Balkrishnan R, Chang J.
Indian J Pharm Sci. 2014;76(2):107-115.


Racial health disparities among special health care needs children with mental disorders: do medical homes cater to their needs?
Park C, Tan X, Patel IB, Reiff A, Balkrishnan R, Chang J.
J Prim Care Community Health. 2014;5(4):253-262.

Factors associated with topical retinoid prescriptions for acne.
Tan X, Davis SA, Balkrishnan R, Krowchuk DP, Feldman SR.
J Dermatolog.Treat. 2014;25(2):110-114.

Infections associated with the use of tumor necrosis factor-alpha inhibitors in psoriasis.
Tan X, Balkrishnan R, Feldman SR.
J Drugs Dermatol. 2013;12(3):e41-e45.

Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris.
Tan X, Al-Dabagh A, Davis SA, Lin HC, Balkrishnan R, Chang J, Feldman SR.
Am J Clin Dermatol. 2013;14(3):243-251.

Topical drug delivery systems in dermatology: a review of patient adherence issues.
Tan X, Feldman SR, Chang J, Balkrishnan R.
Expert Opin Drug Deliv. 2012;9(10):1263-1271.

Beta-catenin regulates vitamin C biosynthesis and cell survival in murine liver.
Nejak-Bowen KN, Zeng G, Tan X, Cieply B, Monga SP.
J Biol Chem. 2009;284(41):28115-28127.


Beta-catenin deletion in hepatoblasts disrupts hepatic morphogenesis and survival during mouse development.
Tan X, Yuan Y, Zeng G, Apte U, Thompson MD, Cieply B, Stolz DB, Michalopoulos GK, Kaestner KH, Monga SP.
Hepatology. 2008;47(5):1667-1679.

Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice.
Apte U, Zeng G, Muller P, Tan X, Micsenyi A, Cieply B, Dai C, Liu Y, Kaestner KH, Monga SP.
Hepatology. 2006;44(4):992-1002.

Conditional deletion of beta-catenin reveals its role in liver growth and regeneration.
Tan X, Behari J, Cieply B, Michalopoulos GK, Monga SP.
Gastroenterology. 2006;131(5):1561-1572.